Literature DB >> 20424282

Treatment of premature ovarian failure trial: description of an ongoing clinical trial.

Beth Cartwright1, Jillian Robinson, Janice Rymer.   

Abstract

Premature ovarian failure is a relatively common clinical condition, and carries important long-term health consequences. Estrogen replacement is recommended to alleviate unpleasant hypo-estrogenic symptoms and reduce long-term health risks. However, the most suitable form of estrogen replacement, and the exact effects of no treatment, is unknown. Surprisingly, little research has been carried out in this area. We describe the design of an ongoing clinical trial that will address these issues so that we can begin to provide evidence-based care for affected women.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20424282     DOI: 10.1258/mi.2010.010010

Source DB:  PubMed          Journal:  Menopause Int        ISSN: 1754-0453


  3 in total

1.  Comparison of CD146 +/- mesenchymal stem cells in improving premature ovarian failure.

Authors:  Lin Zhang; Yang Sun; Xiao-Xu Zhang; Yu-Bin Liu; Hui-Yan Sun; Chu-Tse Wu; Feng-Jun Xiao; Li-Sheng Wang
Journal:  Stem Cell Res Ther       Date:  2022-06-21       Impact factor: 8.079

2.  Electroacupuncture modulates reproductive hormone levels in patients with primary ovarian insufficiency: results from a prospective observational study.

Authors:  Kehua Zhou; Jingxi Jiang; Jiani Wu; Zhishun Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-28       Impact factor: 2.629

3.  Effect of stem cell transplantation of premature ovarian failure in animal models and patients: A meta-analysis and case report.

Authors:  Lei Chen; Shilei Guo; Cui Wei; Honglan Li; Haiya Wang; Yan Xu
Journal:  Exp Ther Med       Date:  2018-03-20       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.